CK Life Sciences Int'l., (Holdings) Inc. Overview

Country:Hong Kong
Industry:Biotechnology and Drugs
Description:
CK Life Sciences Int’l., (Holdings) Inc. is an investment holding company engaged in research and development, manufacturing, commercialization, marketing and selling of environmental and human health products, as well as investment in various financial and investment products. Two products are in advanced stages of clinical development in North America. The Company operated in three segments: environment, health and investment. It is developing a therapeutic vaccine for the treatment of melanoma. It has identified two cancer projects, CKBP002 and CKBP004, for pre-clinical development. CKBP002 is a small molecule purified from a natural plant product. CKBP004 is a small molecule derived from a natural product. It has a product in the Phase III clinical trial for CK Life Sciences’ tetrodotoxin-based (TTX) cancer pain... (More)

Get Trial Access to OneSource

Company profiles, executive contacts, industry research, and news for sales, marketing and research professionals.

Disclaimer: While the OneSource Subscription Service maintains the freshest, most accurate data possible, this free site is refreshed on a periodic basis and may occasionally contain information that is not current. If you would like to alert us to a change, please email us, and we will take steps to make sure your update is included as soon as possible

CK Life Sciences Int'l., (Holdings) Inc. Overview

Get Trial Access to OneSource

Business Information

Executive Profiles

Company Lists